The osteogenesis of Ginsenoside Rb1 incorporated silk/micro-nano hydroxyapatite/sodium alginate composite scaffolds for calvarial defect

Abstract

Ginsenoside Rb1, the effective constituent of ginseng, has been demonstrated to play favorable roles in improving the immunity system. However, there is little study on the osteogenesis and angiogenesis effect of Ginsenoside Rb1. Moreover, how to establish a delivery system of Ginsenoside Rb1 and its repairment ability in bone defect remains elusive. In this study, the role of Ginsenoside Rb1 in cell viability, proliferation, apoptosis, osteogenic genes expression, ALP activity of rat BMSCs were evaluated firstly. Then, micro-nano HAp granules combined with silk were prepared to establish a delivery system of Ginsenoside Rb1, and the osteogenic and angiogenic effect of Ginsenoside Rb1 loaded on micro-nano HAp/silk in rat calvarial defect models were assessed by sequential fluorescence labeling, and histology analysis, respectively. It revealed that Ginsenoside Rb1 could maintain cell viability, significantly increased ALP activity, osteogenic and angiogenic genes expression. Meanwhile, micro-nano HAp granules combined with silk were fabricated smoothly and were a delivery carrier for Ginsenoside Rb1. Significantly, Ginsenoside Rb1 loaded on micro-nano HAp/silk could facilitate osteogenesis and angiogenesis. All the outcomes hint that Ginsenoside Rb1 could reinforce the osteogenesis differentiation and angiogenesis factor’s expression of BMSCs. Moreover, micro-nano HAp combined with silk could act as a carrier for Ginsenoside Rb1 to repair bone defect.

References

[1] Liu Y, . Integration of a calcined bovine bone and BMSC-sheet 3D scaffold and the promotion of bone regeneration in large defects. Biomaterials, 2013, 34: 9998-10006.

[2] Wu Y, . Evaluation of osteogenesis and angiogenesis of icariin loaded on micro/nano hybrid structured hydroxyapatite granules as a local drug delivery system for femoral defect repair. J. Mater. Chem. B, 2015, 3: 4871-4883.

[3] Siddiqi MH, . Ginseng saponins and the treatment of osteoporosis: mini literature review. J. Ginseng Res., 2013, 37: 261-268.

[4] Park EK, . Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. Biol. Pharm. Bull., 2005, 28: 652-656.

[5] Wang CZ, . Steamed American ginseng berry: ginsenoside analyses and anticancer activities. J. Agric Food Chem., 2006, 54: 9936-9942.

[6] Cheng Y, Shen LH, Zhang JT. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharm. Sin., 2005, 26: 143-149.

[7] Qi LW, Wang CZ, Yuan CS. Ginsenosides from American ginseng: chemical and pharmacological diversity. Phytochemistry, 2011, 72: 689-699.

[8] Jia JM, Wang ZQ, Wu LJ, Wu YL. [Advance of pharmacological study on ginsenoside Rb1]. Zhongguo Zhong Yao Za Zhi, 2008, 33: 1371-1377.

[9] Keum YS, . Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. Cancer Lett., 2000, 150: 41-48.

[10] Mohanan P, Subramaniyam S, Mathiyalagan R, Yang DC. Molecular signaling of ginsenosides Rb1, Rg1, and Rg3 and their mode of actions. J. Ginseng Res, 2018, 42: 123-132.

[11] Wang C, . Phenotypic expression of bone-related genes in osteoblasts grown on calcium phosphate ceramics with different phase compositions. Biomaterials, 2004, 25: 2507-2514.

[12] Han YJ, Loo SC, Lee J, Ma J. Investigation of the bioactivity and biocompatibility of different glass interfaces with hydroxyapatite, fluorohydroxyapatite and 58S bioactive glass. Biofactors, 2007, 30: 205-216.

[13] Vepari C, Kaplan DL. Silk as a Biomaterial. Prog. Polym. Sci., 2007, 32: 991-1007.

[14] Zhang W, . The use of injectable sonication-induced silk hydrogel for VEGF(165) and BMP-2 delivery for elevation of the maxillary sinus floor. Biomaterials, 2011, 32: 9415-9424.

[15] Zheng A, . Biocompatible silk/calcium silicate/sodium alginate composite scaffolds for bone tissue engineering. Carbohydr. Polym., 2018, 199: 244-255.

[16] Biswas T, Mathur AK, Mathur A. A literature update elucidating production of Panax ginsenosides with a special focus on strategies enriching the anti-neoplastic minor ginsenosides in ginseng preparations. Appl. Microbiol. Biotechnol., 2017, 101: 4009-4032.

[17] Xie JT, . Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur. J. Pharm., 2006, 532: 201-207.

[18] Tan S, . Anti-inflammatory effect of ginsenoside Rb1 contributes to the recovery of gastrointestinal motility in the rat model of postoperative ileus. Biol. Pharm. Bull., 2014, 37: 1788-1794.

[19] Wang Y, . Ginsenoside Rb1 inhibit apoptosis in rat model of Alzheimer’s disease induced by Abeta1-40. Am. J. Transl. Res, 2018, 10: 796-805.

[20] Zhao J, Lu S, Yu H, Duan S, Zhao J. Baicalin and ginsenoside Rb1 promote the proliferation and differentiation of neural stem cells in Alzheimer’s disease model rats. Brain Res, 2018, 1678: 187-194.

[21] Lo YT, Tsai YH, Wu SJ, Chen JR, Chao JC. Ginsenoside Rb1 inhibits cell activation and liver fibrosis in rat hepatic stellate cells. J. Med. Food, 2011, 14: 1135-1143.

[22] Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell, 1997, 89: 747-754.

[23] Yang SH, Sharrocks AD, Whitmarsh AJ. Transcriptional regulation by the MAP kinase signaling cascades. Gene, 2003, 320: 3-21.

[24] Celil AB, Campbell PG. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J. Biol. Chem., 2005, 280: 31353-31359.

[25] Jaiswal RK, . Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J. Biol. Chem., 2000, 275: 9645-9652.

[26] Cantley LC. The phosphoinositide 3-kinase pathway. Science, 2002, 296: 1655-1657.

[27] Martelli AM, . Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. Leukemia, 2006, 20: 911-928.

[28] Roohani-Esfahani SI, Nouri-Khorasani S, Lu Z, Appleyard R, Zreiqat H. The influence hydroxyapatite nanoparticle shape and size on the properties of biphasic calcium phosphate scaffolds coated with hydroxyapatite-PCL composites. Biomaterials, 2010, 31: 5498-5509.

[29] Zhang W, . An all-silk-derived functional nanosphere matrix for sequential biomolecule delivery and in situ osteochondral regeneration. Bioact. Mater., 2020, 5: 832-843.

[30] Wang X, Yucel T, Lu Q, Hu X, Kaplan DL. Silk nanospheres and microspheres from silk/pva blend films for drug delivery. Biomaterials, 2010, 31: 1025-1035.

[31] Kundu B, Rajkhowa R, Kundu SC, Wang X. Silk fibroin biomaterials for tissue regenerations. Adv. Drug Deliv. Rev., 2013, 65: 457-470.

[32] Rockwood DN, . Materials fabrication from Bombyx mori silk fibroin. Nat. Protoc., 2011, 6: 1612-1631.

[33] Crouzier T, . The performance of BMP-2 loaded TCP/HAP porous ceramics with a polyelectrolyte multilayer film coating. Biomaterials, 2011, 32: 7543-7554.

[34] Przekora A, Ginalska G. Enhanced differentiation of osteoblastic cells on novel chitosan/beta-1,3-glucan/bioceramic scaffolds for bone tissue regeneration. Biomed. Mater., 2015, 10: 015009.

[35] Crisan M, . A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell, 2008, 3: 301-313.

[36] Schott, N. G., Friend, N. E. & Stegemann, J. P. Coupling osteogenesis and vasculogenesis in engineered orthopedic tissues. Tissue Eng. Part B Rev. 27, 199–214 (2021).

[37] Bulnheim U, . Endothelial cells stimulate osteogenic differentiation of mesenchymal stem cells on calcium phosphate scaffolds. J. Tissue Eng. Regen. Med., 2014, 8: 831-840.

[38] Shanbhag S, Pandis N, Mustafa K, Nyengaard JR, Stavropoulos A. Cell cotransplantation strategies for vascularized craniofacial bone tissue engineering: a systematic review and meta-analysis of preclinical in vivo studies. Tissue Eng. Part B Rev., 2017, 23: 101-117.

[39] Bakshi R, . Application of hydroxycholesterols for alveolar cleft osteoplasty in a rodent model. Plast. Reconstr. Surg., 2019, 143: 1385-1395.

[40] Pou AM. Update on new biomaterials and their use in reconstructive surgery. Curr. Opin. Otolaryngol. Head. Neck Surg., 2003, 11: 240-244.

[41] Kao RT, Conte G, Nishimine D, Dault S. Tissue engineering for periodontal regeneration. J. Calif. Dent. Assoc., 2005, 33: 205-215.

[42] Guerrero J, . Cell interactions between human progenitor-derived endothelial cells and human mesenchymal stem cells in a three-dimensional macroporous polysaccharide-based scaffold promote osteogenesis. Acta Biomater., 2013, 9: 8200-8213.

[43] Sun Z, Cai S, Zabkiewicz C, Liu C, Ye L. Bone morphogenetic proteins mediate crosstalk between cancer cells and the tumour microenvironment at primary tumours and metastases (Review). Int J. Oncol., 2020, 56: 1335-1351.

[44] Wu QJ, . Antibacterial property, angiogenic and osteogenic activity of Cu-incorporated TiO₂ coating. J. Mater. Chem. B, 2014, 2: 6738-6748.

[45] Wu Y, . Effect of mechanical stretch on the proliferation and differentiation of BMSCs from ovariectomized rats. Mol. Cell Biochem, 2013, 382: 273-282.

[46] Wu, Q. et al. Study of Sr–Ca–Si-based scaffolds for bone regeneration in osteoporotic models. Int. J. Oral Sci. 12, 25 (2020).